W
#Novartis #Pharmaceuticals #Oncology
www.wsj.com
Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
Novartis is paying $2 billion upfront and up to $1 billion subject to targets to acquire Pikavation Therapeutics. fabrice coffrini/Agence France-Presse/Getty Images
Novartis NOVN -1.
#Diabetes #Generics #Pharmaceuticals
ca.finance.yahoo.com
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires this week, triggering a wave of cheaper generics from local drugmakers and worries about uneven oversight in an overcrowded market.
#PharmaceuticalIndustry #DrugPricing #HealthcareReform
www.nytimes.com
How TrumpRx Drug Prices Compare With Those in Other Countries
Rebecca Robbins covers the pharmaceutical industry. She oversaw data collection from pharmacies in Canada, Denmark, France, Germany, Italy, Japan, Switzerland and Britain.
#MiddleEastConflict #HealthcareSupplyChain #Pharmaceuticals
ca.finance.yahoo.com
Analysis-Middle East war disrupts pharma air routes, risks cancer drugs supply
LONDON, March 16 (Reuters) - War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and forcing companies to reroute flights and find overland access into the region, industry executives said.
#PharmaceuticalIndustry #HealthcareCosts #PrescriptionDrugs
www.yahoo.com
Advocates push lawmakers to end tax break for drug commercials, advertising
Advocates argue that some drug companies spend more on executive salaries, stock buybacks, and advertising than they do on research and development, while pharmaceutical companies claim rising prescription drug costs are driven by research and development expenses.
W
#WeightLossDrugs #PharmaceuticalPricing #HealthcareAccessibility
www.washingtonpost.com
How GLP1s are changing the ways Americans buy medicine
Ashley Elizabeth Harden logged on recently from her home in small-town Louisiana and searched for a weight-loss drug. She found plenty of options and settled on a cheaper, imitation version of the name-brand drugs for $177 a month that she could buy without going through insurance.
#ArtificialIntelligence #Pharmaceuticals #DrugManufacturing
www.forbes.com
How Lilly Used AI To Crank Up Production Of Its Popular GLP-1s
Forget the drug discovery hype. Here's how the world's largest pharma company is seeing a payoff from AI right now.
here's been huge hype around AI's potential for drug discovery.
#DrugPrices #Healthcare #Pharmaceuticals
www.newsweek.com
List of medications seeing major price changes in 2026
A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the manufacturers that made deals with the Trump administration to lower prices.
#HenriettaLacks #MedicalEthics #PharmaceuticalIndustry
www.nytimes.com
Henrietta Lacks's Family Settles Suit With Novartis Over Use of Her Cells
The pharmaceutical giant Novartis has reached a settlement with the family of Henrietta Lacks, a Black woman whose cells were taken from her without her consent in 1951, when she was dying of cervical cancer in a segregated ward at Johns Hopkins Hospital in Baltimore.
#HenriettaLacks #MedicalEthics #Pharmaceuticals
us.cnn.com
Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine | CNN
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
#HenriettaLacks #MedicalEthics #PharmaceuticalIndustry
www.cbsnews.com
Novartis settles with woman's estate over use of her "stolen" cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advances, including the polio vaccine.
#HenriettaLacks #MedicalEthics #PharmaceuticalJustice
www.cbsnews.com
Novartis settles with Henrietta Lacks' estate over use of her "stolen" cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
